Filtered By:
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 231 results found since Jan 2013.
Prevalence of self-reported food allergy in the National Health and Nutrition Examination Survey (NHANES) 2007-2010
Food allergy is a common condition, with widely varying estimates of prevalence worldwide and within the United States. The National Health and Nutrition Examination Survey (NHANES) is a periodic survey conducted by the National Center for Health Statistics of the Centers for Disease Control and Prevention that examines a nationally representative sample of approximately 5000 subjects each year. Further description of can be found in this article's Online Repository at www.jacionline.org. In the 2 most recently published NHANES, 2007-2008 and 2009-2010, information on specific food allergies was collected by questionnaire....
Source: Journal of Allergy and Clinical Immunology - September 3, 2013 Category: Allergy & Immunology Authors: Emily C. McGowan, Corinne A. Keet Tags: Letters to the Editor Source Type: research
Establishing the safety of influenza vaccine in egg-allergic individuals.
This article will trace the evolution of this practice.
PMID: 23805959 [PubMed - in process]
Source: Pediatric Annals - July 1, 2013 Category: Pediatrics Authors: Greenhawt MJ Tags: Pediatr Ann Source Type: research
CDC Immunization Experts OK Egg-Free Influenza VaccineCDC Immunization Experts OK Egg-Free Influenza Vaccine
Members of the Centers for Disease Control and Prevention's immunization committee have voted unanimously to recommend the egg-free vaccine Flublok as an option for people with severe egg allergy. Medscape Medical News
Source: Medscape Today Headlines - June 21, 2013 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Recent HIV/AIDS News from CDC, FDA, and NIAID
June 12, 2013: Study Finds First Evidence That PrEP Can Reduce HIV Risk Among People Who Inject Drugs
“A daily dose of a medication used to treat HIV infection reduced the risk of HIV acquisition among people who inject drugs by 49 percent. Those who took the medication most consistently had even higher levels of protection, according to a new study announced today by the Centers for Disease Control and Prevention – in collaboration with the Bangkok Metropolitan Administration (BMA) and the Thailand Ministry of Public Health (MOPH).
"This is the first evidence that pre-exposure prophylaxis (PrEP)...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - June 14, 2013 Category: Infectious Diseases Source Type: news
News and More News About Flu Season 2012-13
News about the 2012-2013 influenza (or “flu”) season has been everywhere recently. The cities of Boston and New York have declared public health emergencies, and Dr. Anthony Facui, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, has indicated that we are in what is classically described as a flu epidemic. The Centers for Disease Control and Prevention reported 22,048 flu cases from September 30 – December 31, 2012, compared with 849 cases reported during the same time frame in 2011 (http://www.cdc.gov/flu/weekly/).
One of the ways librarians and ...
Source: Network News - January 18, 2013 Category: Databases & Libraries Authors: Cheryl Rowan Tags: Consumer Health General (all entries) Public Health Source Type: news
A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment
Commentary on: Garbutt JM, Banister C, Spitznagel E, et al.. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA 2012;307:685–92 . Context Despite the controversy regarding their clinical benefit and concerns about resistance, the use of antimicrobials for rhinosinusitis (RS) accounts for one in five prescriptions for adults in the USA. However, we lack a simple diagnostic or predictive tool for determining whether acute viral RS has progressed to secondary bacterial RS, and must therefore rely on a patient's history and limited physical findings to diagnose RS. Using guidelines recommended by a...
Source: Evidence-Based Medicine - January 17, 2013 Category: Internal Medicine Authors: Anon, J., Ferguson, B. J., Jacobs, M. R. Tags: Clinical trials (epidemiology), Immunology (including allergy), Otitis, Headache (including migraine), Pain (neurology), Ear, nose and throat/otolaryngology Therapeutics Source Type: research
